## Abstract The Parkinson's Disease Sleep Scale (PDSS) is the first published bedside clinical tool to specifically measure sleep disturbances in Parkinson's disease (PD). The objective of the present study was to carry out a metric analysis of a Spanish version (PDSS‐SV) using a cross‐sectional st
Parkinson's disease sleep scale—validation of the revised version PDSS-2
✍ Scribed by Claudia Trenkwalder; Ralf Kohnen; Birgit Högl; Vinod Metta; Friederike Sixel-Döring; Birgit Frauscher; Julia Hülsmann; Pablo Martinez-Martin; Kallol Ray Chaudhuri
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 474 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background:
The previous Parkinson's disease sleep scale (PDSS) is a 15‐item visual analogue scale that assesses the profile of nocturnal disturbances in Parkinson's disease (PD) patients.
Objective:
To extend the scale so that it becomes a frequency measure scale with five categories and encompasses unmet needs such as restless legs syndrome, akinesia, pain, and sleep apnea.
Methods:
For validation of the PDSS‐2, PD patients' ratings and investigators' interviews were compared to ratings from a semistructured interview with a caregiver/partner, and to related scales. PDSS‐2 was repeated for test‐retest‐reliability after 1–3 days.
Results:
A total of 113 PD patients showed a mean (SD) total score of 16.5 (±8.9) (range: 2–40) indicating mild to moderate sleep disturbances. PDSS‐2 item‐total correlation for proving internal consistency was satisfactory (correlations >0.30). From a factor analysis, three subscales were derived: (1) “motor problems at night,” (2) “PD symptoms at night” and (3) “disturbed sleep.” The alpha coefficient for the total score was 0.73, for subscales 0.47 to 0.66. The test‐retest‐reliability intra‐class‐coefficient for the total score was 0.80, with 0.69 and 0.77 within the subscales. For discriminative validity, significant differences were found in the PDSS‐2 total score depending on CGI and Hoehn and Yahr severity levels. A comparison between caregivers' and patients' ratings was carried out.
Conclusion:
The PDSS‐2, with an extended spectrum of nocturnal disabilities and easier use for patients, is a reliable, valid, precise, and potentially treatment‐responsive tool for measuring sleep disorders in PD. © 2011 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract This study evaluated the comparative validity and usefulness of the Parkinson's Disease Sleep Scale (PDSS) and the Scales for Outcomes in PD‐Sleep Scale (SCOPA‐S), two disease‐specific rating scales for assessing sleep disorders in Parkinson's disease (PD). Hoehn and Yahr staging (HY),
## Abstract Depression in Parkinson's disease (dPD) is difficult to diagnose because depressive symptoms can overlap with symptoms of Parkinson's disease (PD). Subject‐rated scales such as the 30‐item Geriatric Depression Scale (GDS) may be useful in screening for dPD. There were 57 patients (33 me
## Abstract The objective of this study was to examine the validity of the mentation, behavior, and mood items included in Part I of the Unified Parkinson's Disease Rating Scale (UPDRS) and to assess its usefulness to screen for dementia, psychosis, depression, and apathy. A consecutive series of 1
Sialorrhea is common in Parkinson disease (PD), affecting approximately 70% to 75% of patients. Several tools for measuring saliva volume or production exist, but none are designed specifically for assessing sialorrhea-related discomfort. The objective of this study was to develop and validate a cli
## Abstract ## Objectives This study aims to examine the psychometric properties of the Chinese version of the Alzheimer's disease behavioral pathology rating scale (CBehave‐AD) and the behavioral profile of Chinese patients with AD. ## Methods Seventy‐one subjects with NINCDS‐ADRDA diagnosis of